Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2176 to 2190 of 8236 results

  1. EchoLaser percutaneous laser ablation treatment for patients with neck lesions

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  2. Polydioxanone stents for the therapy of Tracheal stenosis: adults

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  3. Percutaneous Laser Ablation (PLA) for benign thyroid nodules

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  4. Electromagnetic stimulation to promote healing of non-union fractures

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  5. Lutetium (177Lu) oxodotreotide for treating SSTR-positive advanced or inoperable gastroenteropancreatic neuroendocrine tumours in people 12 to 17 years [TSID12154]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  6. Rezafungin for preventing invasive fungal infections after an allogeneic blood and marrow transplant [TSID12165]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  7. Leniolisib for untreated activated phosphoinositide 3-kinase delta syndrome in children 4 to 11 years [TSID12190]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  8. Fidrisertib for reducing heterotopic ossification caused by fibrodysplasia ossificans progressiva in people 5 years and over [TSID12216]

    Awaiting development Reference number: GID-TA11805 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  9. Tildrakizumab for treating active psoriatic arthritis [TSID12218]

    Awaiting development Reference number: GID-TA11807 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  10. Tiragolumab–atezolizumab for PD-L1-positive recurrent or advanced non-small-cell lung cancer untreated with checkpoint inhibitors [TSID12064]

    Awaiting development Reference number: GID-TA11594 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  11. Chemical Component Separation

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  12. Extracorporeal bioartificial liver assist therapy

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  13. Inserting a bupivicaine-collagen implant into a surgical wound for postoperative analgesia

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  14. An aortic cuff counterpulsation system for the treatment of heart failure

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  15. Use of a glue or sealant to achieve lung volume reduction in emphysema and lung cancer

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation